Table 3.
Correlation between HSP and GAPDH mRNA levels
| Gene name (vs. GAPDH) | Slope (R2)
|
||
|---|---|---|---|
| TI | ASP | SCD | |
| HSPA1A | 0.2191 (0.0184) | 0.4981 (0.1748) | 0.6595 (0.2105) |
| HSPA1B | 0.3977 (0.0602) | 0.8076 (0.3977) | 0.7671 (0.3392) |
| HSPA2 | 0.6440 (0.2532) | 0.4944 (0.1100) | 0.7468 (0.2596) |
| HSPA7 | 0.0672 (0.0016) | 0.0285 (0.0031) | −0.0956 (0.0052) |
| HSPA13 | 0.0669 (0.0019) | 0.1465 (0.0193) | −0.0814 (0.0087) |
| HSPA4 | 0.9944 (0.7868) | 0.9781 (0.8245) | 0.8459 (0.6770) |
| HSPA5 | 1.2393 (0.6999) | 1.2014 (0.6469) | 1.1153 (0.6135) |
| HSPA8 | 1.4790 (0.9336) | 1.2918 (0.8583) | 1.3844 (0.9003) |
| HSPA9 | 1.1677 (0.9513) | 1.1678 (0.8827) | 1.1603 (0.8491) |
| HSPA12A | 1.3192 (0.7621) | 1.4035 (0.6470) | 0.9991 (0.5962) |
| HSPD1 | 0.7583 (0.5742) | 0.8311 (0.7421) | 0.8386 (0.8277) |
| HSPH1 | 1.8179 (0.8058) | 1.6483 (0.8318) | 1.8931 (0.9326) |
| HSP90AA1 | 0.8901 (0.5900) | 0.8507 (0.6250) | 0.9569 (0.6496) |
GAPDH, glyceraldehyde 3-phosphate dehydrogenase; TI, traumatic injury; ASP, asphyxiation; SCD, sudden cardiac death